CLINICAL_TRIALS
trial_result
· 2020-12-04
Clinical Trial Update: Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria [Phase 4]
Summary
Phase 4 trial investigating the effect of omalizumab (Xolair) on basophils in patients with chronic idiopathic urticaria.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Chronic Urticaria | Phase 4 | Status: COMPLETED | Results posted: 2020-12-04